

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.01931358 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.01931358 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.79931376 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.79931376 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.49918967 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49867072 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.44101370 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.06786567 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.98905051 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.98905051 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.98905051 |
| 12 | hemoglobin metabolic process (GO:0020027) | 4.91672397 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89600511 |
| 14 | oxygen transport (GO:0015671) | 4.87340735 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.84982674 |
| 16 | lysine catabolic process (GO:0006554) | 4.84732004 |
| 17 | lysine metabolic process (GO:0006553) | 4.84732004 |
| 18 | complement activation, alternative pathway (GO:0006957) | 4.83653663 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.81826663 |
| 20 | regulation of protein activation cascade (GO:2000257) | 4.68837554 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.66489201 |
| 22 | urea metabolic process (GO:0019627) | 4.62434613 |
| 23 | urea cycle (GO:0000050) | 4.62434613 |
| 24 | low-density lipoprotein particle clearance (GO:0034383) | 4.60095499 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.58646235 |
| 26 | protein carboxylation (GO:0018214) | 4.58646235 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.57892166 |
| 28 | cysteine metabolic process (GO:0006534) | 4.57839465 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.57331250 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 4.56211369 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.48979787 |
| 32 | regulation of complement activation (GO:0030449) | 4.45097848 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.38778964 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.31205776 |
| 35 | gas transport (GO:0015669) | 4.27221743 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.25237664 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.23925260 |
| 38 | ethanol oxidation (GO:0006069) | 4.20344713 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13224840 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.12112161 |
| 41 | bile acid metabolic process (GO:0008206) | 4.11201582 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.11135512 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.08352479 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06106064 |
| 45 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.03646021 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.99094855 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.99094855 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 3.99094855 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 3.98901843 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.95446822 |
| 51 | endothelium development (GO:0003158) | 3.92847810 |
| 52 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92495301 |
| 53 | triglyceride homeostasis (GO:0070328) | 3.92284328 |
| 54 | acylglycerol homeostasis (GO:0055090) | 3.92284328 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.90858469 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.88063944 |
| 57 | phospholipid efflux (GO:0033700) | 3.88038490 |
| 58 | aromatic amino acid family metabolic process (GO:0009072) | 3.86644398 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.86427424 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85189970 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.82429973 |
| 62 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81178015 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.81096719 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.80879076 |
| 65 | definitive hemopoiesis (GO:0060216) | 3.79930092 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.76641268 |
| 67 | negative regulation of cell killing (GO:0031342) | 3.76641268 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.73883836 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.72997557 |
| 70 | valine metabolic process (GO:0006573) | 3.68822995 |
| 71 | carnitine metabolic process (GO:0009437) | 3.68562076 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.67422888 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.66393291 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.66393291 |
| 75 | fatty acid oxidation (GO:0019395) | 3.66388095 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.66146746 |
| 77 | glutamate metabolic process (GO:0006536) | 3.64649681 |
| 78 | fatty acid transmembrane transport (GO:1902001) | 3.62329248 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.62077350 |
| 80 | lipid oxidation (GO:0034440) | 3.61791781 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.61284519 |
| 82 | triglyceride catabolic process (GO:0019433) | 3.61181021 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.59584036 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 3.59412079 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.58395110 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.56349536 |
| 87 | fatty acid catabolic process (GO:0009062) | 3.55193278 |
| 88 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.49969859 |
| 89 | cholesterol efflux (GO:0033344) | 3.49680523 |
| 90 | monocarboxylic acid catabolic process (GO:0072329) | 3.48885826 |
| 91 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47808430 |
| 92 | bile acid and bile salt transport (GO:0015721) | 3.43704789 |
| 93 | amine catabolic process (GO:0009310) | 3.41310379 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.41310379 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.40823622 |
| 96 | complement activation (GO:0006956) | 3.40745782 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 3.40469320 |
| 98 | organic acid catabolic process (GO:0016054) | 3.40088702 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.40088702 |
| 100 | negative regulation of granulocyte differentiation (GO:0030853) | 3.39652288 |
| 101 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.39624127 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.39562734 |
| 103 | protein activation cascade (GO:0072376) | 3.36128081 |
| 104 | positive regulation of fatty acid oxidation (GO:0046321) | 3.35356833 |
| 105 | ketone body metabolic process (GO:1902224) | 3.34500357 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.33085624 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 3.31584261 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.31032023 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30371915 |
| 110 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30371915 |
| 111 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30027085 |
| 112 | cellular glucuronidation (GO:0052695) | 3.29711843 |
| 113 | protein-lipid complex assembly (GO:0065005) | 3.29683034 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.29314459 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.28970748 |
| 116 | negative regulation of phagocytosis (GO:0050765) | 3.27843084 |
| 117 | fibrinolysis (GO:0042730) | 3.26771497 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.26463629 |
| 119 | arginine metabolic process (GO:0006525) | 3.24917788 |
| 120 | detection of other organism (GO:0098543) | 3.24660214 |
| 121 | detection of bacterium (GO:0016045) | 3.24656287 |
| 122 | glycine metabolic process (GO:0006544) | 3.24034365 |
| 123 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.22317707 |
| 124 | acylglycerol catabolic process (GO:0046464) | 3.20402465 |
| 125 | neutral lipid catabolic process (GO:0046461) | 3.20402465 |
| 126 | neutrophil activation involved in immune response (GO:0002283) | 3.10086530 |
| 127 | regulation of platelet aggregation (GO:0090330) | 3.08258274 |
| 128 | positive thymic T cell selection (GO:0045059) | 3.00312537 |
| 129 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.98383713 |
| 130 | regulation of granulocyte differentiation (GO:0030852) | 2.97469730 |
| 131 | regulation of macrophage cytokine production (GO:0010935) | 2.88529129 |
| 132 | positive regulation of B cell differentiation (GO:0045579) | 2.87838121 |
| 133 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87559701 |
| 134 | cellular response to epinephrine stimulus (GO:0071872) | 2.87186226 |
| 135 | erythrocyte development (GO:0048821) | 2.85784857 |
| 136 | heme biosynthetic process (GO:0006783) | 2.84377262 |
| 137 | regulation of cholesterol storage (GO:0010885) | 2.81634603 |
| 138 | barbed-end actin filament capping (GO:0051016) | 2.76899210 |
| 139 | positive regulation of macrophage cytokine production (GO:0060907) | 2.76811515 |
| 140 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76210780 |
| 141 | erythrocyte maturation (GO:0043249) | 2.74303018 |
| 142 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.73537566 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.72445065 |
| 144 | angiogenesis involved in wound healing (GO:0060055) | 2.71978495 |
| 145 | response to interleukin-15 (GO:0070672) | 2.71924865 |
| 146 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.70884598 |
| 147 | Peyers patch development (GO:0048541) | 2.70884598 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.70754703 |
| 149 | lipid storage (GO:0019915) | 2.64632569 |
| 150 | regulation of T cell tolerance induction (GO:0002664) | 2.63794318 |
| 151 | positive regulation of cholesterol efflux (GO:0010875) | 2.63002729 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62201204 |
| 153 | regulation of mast cell degranulation (GO:0043304) | 2.61722718 |
| 154 | diacylglycerol metabolic process (GO:0046339) | 2.59141809 |
| 155 | thymic T cell selection (GO:0045061) | 2.58735182 |
| 156 | porphyrin-containing compound metabolic process (GO:0006778) | 2.58173474 |
| 157 | negative T cell selection (GO:0043383) | 2.56993083 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.56950974 |
| 159 | regulation of necroptotic process (GO:0060544) | 2.55545295 |
| 160 | germinal center formation (GO:0002467) | 2.54729422 |
| 161 | myeloid cell development (GO:0061515) | 2.54350502 |
| 162 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.54344682 |
| 163 | negative thymic T cell selection (GO:0045060) | 2.53960466 |
| 164 | negative regulation of type 2 immune response (GO:0002829) | 2.53808673 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53555633 |
| 166 | tetrapyrrole biosynthetic process (GO:0033014) | 2.53261529 |
| 167 | positive regulation of tolerance induction (GO:0002645) | 2.52304824 |
| 168 | negative regulation of necroptotic process (GO:0060546) | 2.52108510 |
| 169 | blood vessel maturation (GO:0001955) | 2.52067187 |
| 170 | positive T cell selection (GO:0043368) | 2.48504177 |
| 171 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.47943495 |
| 172 | heme metabolic process (GO:0042168) | 2.47535705 |
| 173 | T cell selection (GO:0045058) | 2.44005302 |
| 174 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.43712890 |
| 175 | regulation of tolerance induction (GO:0002643) | 2.42643811 |
| 176 | response to peptidoglycan (GO:0032494) | 2.42615808 |
| 177 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.42207206 |
| 178 | positive regulation of vasculogenesis (GO:2001214) | 2.41999791 |
| 179 | positive regulation of Rap GTPase activity (GO:0032854) | 2.40691979 |
| 180 | protein kinase C signaling (GO:0070528) | 2.40274919 |
| 181 | megakaryocyte development (GO:0035855) | 2.38823529 |
| 182 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.38397868 |
| 183 | cellular hyperosmotic response (GO:0071474) | 2.37926014 |
| 184 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.37877966 |
| 185 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36543208 |
| 186 | positive regulation of receptor recycling (GO:0001921) | 2.36401032 |
| 187 | regulation of response to osmotic stress (GO:0047484) | 2.36270775 |
| 188 | mature B cell differentiation involved in immune response (GO:0002313) | 2.35764566 |
| 189 | positive regulation of granulocyte differentiation (GO:0030854) | 2.35505214 |
| 190 | regulation of B cell differentiation (GO:0045577) | 2.35483580 |
| 191 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34773211 |
| 192 | modulation by symbiont of host immune response (GO:0052553) | 2.34773211 |
| 193 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34773211 |
| 194 | modulation by symbiont of host defense response (GO:0052031) | 2.34773211 |
| 195 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34773211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.65355249 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.74883730 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.95350537 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.80670513 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.42775824 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.06508563 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.53854548 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.66825715 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.51939242 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70179442 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64671247 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63044984 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47111863 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31484400 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12424462 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04859094 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98930459 |
| 18 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.98209532 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.94493044 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86572525 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83635499 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76105218 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75946116 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75254702 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73488158 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.72285845 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72044299 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63215323 |
| 29 | * MAF_26560356_Chip-Seq_TH2_Human | 1.62690492 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58047185 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56214370 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56002317 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54981522 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51464363 |
| 35 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47651755 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46635559 |
| 37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45557156 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43335481 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41828277 |
| 40 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41290512 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.39036786 |
| 42 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.38457078 |
| 43 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37545726 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.37187681 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35284182 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33907000 |
| 47 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.33186257 |
| 48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26440211 |
| 49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25580376 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25352825 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.24906265 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24687193 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23490229 |
| 54 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.20094547 |
| 55 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19690304 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19263973 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18345793 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17742815 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17586516 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16920016 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15175393 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15064927 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13591935 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12428767 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11710968 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11508052 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10818396 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10529599 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10380010 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09081582 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08881165 |
| 72 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08648378 |
| 73 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08648378 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07909917 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07292557 |
| 76 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.07147140 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06467219 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05269414 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03839349 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03706039 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02861202 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01290843 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01163079 |
| 84 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.99988137 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99735789 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98718740 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98310979 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95688419 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94964860 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93919400 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93585386 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93305553 |
| 93 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92654658 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91344067 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91291847 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90263160 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90150788 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87233994 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86200249 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85396466 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82978531 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82318319 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82000851 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81967986 |
| 105 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81176481 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81117692 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80443742 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79423352 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77994963 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76549898 |
| 111 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.73596808 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 0.73583065 |
| 113 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72956412 |
| 114 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71931836 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71881822 |
| 116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70755374 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69705436 |
| 118 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69195246 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69124851 |
| 120 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67935093 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67436486 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67348064 |
| 123 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65958943 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64752141 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.64500751 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63977811 |
| 127 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61706679 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.60853603 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60056105 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.59846755 |
| 131 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58952903 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58614679 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58614679 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57044256 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.56387149 |
| 136 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56330925 |
| 137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56223296 |
| 138 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55803439 |
| 139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54874273 |
| 140 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54835815 |
| 141 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54427164 |
| 142 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.54269360 |
| 143 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54140823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.44980701 |
| 2 | MP0005360_urolithiasis | 6.04139469 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.03901774 |
| 4 | MP0005365_abnormal_bile_salt | 4.93054958 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.04679085 |
| 6 | MP0009840_abnormal_foam_cell | 3.28806382 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.25825629 |
| 8 | MP0003252_abnormal_bile_duct | 3.19707496 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.12191207 |
| 10 | MP0005083_abnormal_biliary_tract | 2.84374413 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.69451801 |
| 12 | MP0005332_abnormal_amino_acid | 2.42728315 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.24896790 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.24896790 |
| 15 | MP0009278_abnormal_bone_marrow | 2.23811672 |
| 16 | MP0000609_abnormal_liver_physiology | 2.07724818 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.05170075 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.03017497 |
| 19 | MP0004130_abnormal_muscle_cell | 2.00533682 |
| 20 | MP0005670_abnormal_white_adipose | 1.99060504 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.98653684 |
| 22 | MP0003195_calcinosis | 1.98076950 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.91469386 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.86602653 |
| 25 | MP0002132_abnormal_respiratory_system | 1.81599424 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.79799124 |
| 27 | MP0005025_abnormal_response_to | 1.76319098 |
| 28 | MP0008260_abnormal_autophagy | 1.72427100 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.71494089 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.70127312 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.68911871 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.67824650 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.67234730 |
| 34 | MP0009785_altered_susceptibility_to | 1.62798097 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59360003 |
| 36 | MP0005387_immune_system_phenotype | 1.57776685 |
| 37 | MP0001790_abnormal_immune_system | 1.57776685 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.56840094 |
| 39 | MP0002405_respiratory_system_inflammati | 1.51494647 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.48081653 |
| 41 | MP0003724_increased_susceptibility_to | 1.45671880 |
| 42 | MP0001819_abnormal_immune_cell | 1.45095614 |
| 43 | MP0001800_abnormal_humoral_immune | 1.41273804 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.38771058 |
| 45 | MP0005671_abnormal_response_to | 1.38456135 |
| 46 | MP0002723_abnormal_immune_serum | 1.32793069 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.30325626 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.29527333 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.29385595 |
| 50 | MP0002398_abnormal_bone_marrow | 1.29253825 |
| 51 | MP0001764_abnormal_homeostasis | 1.26812690 |
| 52 | MP0009764_decreased_sensitivity_to | 1.26481528 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.22460451 |
| 54 | MP0003868_abnormal_feces_composition | 1.19758675 |
| 55 | MP0008004_abnormal_stomach_pH | 1.17815830 |
| 56 | MP0004147_increased_porphyrin_level | 1.17451458 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.16971013 |
| 58 | MP0003690_abnormal_glial_cell | 1.15193888 |
| 59 | MP0003186_abnormal_redox_activity | 1.14910042 |
| 60 | MP0006082_CNS_inflammation | 1.14697790 |
| 61 | MP0002254_reproductive_system_inflammat | 1.14656080 |
| 62 | MP0002933_joint_inflammation | 1.14387394 |
| 63 | MP0003646_muscle_fatigue | 1.13576597 |
| 64 | MP0000604_amyloidosis | 1.12656775 |
| 65 | MP0008469_abnormal_protein_level | 1.10960383 |
| 66 | MP0000598_abnormal_liver_morphology | 1.10839389 |
| 67 | MP0009763_increased_sensitivity_to | 1.10693689 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.09658382 |
| 69 | MP0005451_abnormal_body_composition | 1.09559643 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.08696509 |
| 71 | MP0002722_abnormal_immune_system | 1.08420242 |
| 72 | MP0002970_abnormal_white_adipose | 1.08351753 |
| 73 | MP0002971_abnormal_brown_adipose | 1.07384622 |
| 74 | MP0004084_abnormal_cardiac_muscle | 1.07086128 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.05467197 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.05361700 |
| 77 | MP0003011_delayed_dark_adaptation | 1.05089723 |
| 78 | MP0000716_abnormal_immune_system | 1.03913849 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.01104755 |
| 80 | MP0001853_heart_inflammation | 1.00889060 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.00042646 |
| 82 | MP0005330_cardiomyopathy | 0.98922575 |
| 83 | MP0004036_abnormal_muscle_relaxation | 0.97023718 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.95971951 |
| 85 | MP0005647_abnormal_sex_gland | 0.95280873 |
| 86 | MP0003878_abnormal_ear_physiology | 0.95038456 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.95038456 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.95025430 |
| 89 | MP0002429_abnormal_blood_cell | 0.94747430 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.94249516 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.93557984 |
| 92 | MP0009697_abnormal_copulation | 0.93441214 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.93160235 |
| 94 | MP0005164_abnormal_response_to | 0.91783649 |
| 95 | MP0004381_abnormal_hair_follicle | 0.91078078 |
| 96 | MP0005334_abnormal_fat_pad | 0.90473643 |
| 97 | MP0003436_decreased_susceptibility_to | 0.90329821 |
| 98 | MP0004947_skin_inflammation | 0.90117337 |
| 99 | MP0003075_altered_response_to | 0.88604302 |
| 100 | MP0003866_abnormal_defecation | 0.87916014 |
| 101 | MP0000343_altered_response_to | 0.87395279 |
| 102 | MP0004510_myositis | 0.86182694 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.85545425 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.85461400 |
| 105 | MP0005535_abnormal_body_temperature | 0.83155205 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.82072241 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 0.81643030 |
| 108 | MP0005385_cardiovascular_system_phenoty | 0.81643030 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.81610951 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.81561303 |
| 111 | MP0001851_eye_inflammation | 0.81192659 |
| 112 | MP0000858_altered_metastatic_potential | 0.80640843 |
| 113 | MP0004484_altered_response_of | 0.80346584 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.80241249 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.80111330 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.80077663 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.78988571 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.75823519 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.73137177 |
| 120 | MP0000751_myopathy | 0.72990938 |
| 121 | MP0003303_peritoneal_inflammation | 0.72364647 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.72157262 |
| 123 | MP0000249_abnormal_blood_vessel | 0.70645645 |
| 124 | MP0001756_abnormal_urination | 0.70153138 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.69540646 |
| 126 | MP0000749_muscle_degeneration | 0.69307503 |
| 127 | MP0006138_congestive_heart_failure | 0.68643698 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.67757937 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.67545875 |
| 130 | MP0005166_decreased_susceptibility_to | 0.67136623 |
| 131 | MP0002269_muscular_atrophy | 0.66208944 |
| 132 | MP0005165_increased_susceptibility_to | 0.65992195 |
| 133 | MP0009115_abnormal_fat_cell | 0.63805885 |
| 134 | MP0002419_abnormal_innate_immunity | 0.63143767 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.62968709 |
| 136 | MP0001661_extended_life_span | 0.62945397 |
| 137 | MP0003329_amyloid_beta_deposits | 0.62671307 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.62096501 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.62078903 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.61703472 |
| 141 | MP0005266_abnormal_metabolism | 0.61308980 |
| 142 | MP0001835_abnormal_antigen_presentation | 0.61082619 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.58168569 |
| 144 | MP0008874_decreased_physiological_sensi | 0.57294014 |
| 145 | MP0003828_pulmonary_edema | 0.55979296 |
| 146 | MP0000685_abnormal_immune_system | 0.55786549 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.55705294 |
| 148 | MP0001845_abnormal_inflammatory_respons | 0.55683264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.37796847 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.12177988 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.61689488 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.55461539 |
| 5 | Xanthomatosis (HP:0000991) | 5.46794834 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.24876471 |
| 7 | Complement deficiency (HP:0004431) | 5.21794996 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.92068903 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.87952268 |
| 10 | Hypochromic anemia (HP:0001931) | 4.59157753 |
| 11 | Microcytic anemia (HP:0001935) | 4.51269594 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.35660175 |
| 13 | Hyperammonemia (HP:0001987) | 4.28074741 |
| 14 | Ketosis (HP:0001946) | 4.23648917 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.20710920 |
| 16 | Joint hemorrhage (HP:0005261) | 4.08812433 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.01962583 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.00155910 |
| 19 | Hyperglycinuria (HP:0003108) | 3.85201035 |
| 20 | Abnormality of complement system (HP:0005339) | 3.82633968 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.79857048 |
| 22 | Epidermoid cyst (HP:0200040) | 3.65251995 |
| 23 | Myositis (HP:0100614) | 3.63316191 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.60751309 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60751309 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.60545341 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.53851458 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49539225 |
| 29 | Ketoacidosis (HP:0001993) | 3.49324266 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.46718387 |
| 31 | Hyperglycinemia (HP:0002154) | 3.45471200 |
| 32 | Abnormal hemoglobin (HP:0011902) | 3.44844946 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.44179939 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.43589362 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.37468070 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.34847442 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28683178 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.18447947 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18352519 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 3.15847808 |
| 41 | Difficulty running (HP:0009046) | 3.11486914 |
| 42 | Myocardial infarction (HP:0001658) | 3.10499233 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.07042802 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.05663049 |
| 45 | Orchitis (HP:0100796) | 3.04456133 |
| 46 | Hyperbilirubinemia (HP:0002904) | 3.01769719 |
| 47 | Colitis (HP:0002583) | 2.98813869 |
| 48 | Fat malabsorption (HP:0002630) | 2.98779213 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.96773591 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.96416800 |
| 51 | Hyporeflexia of lower limbs (HP:0002600) | 2.95613514 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.95330500 |
| 53 | Hematochezia (HP:0002573) | 2.84954315 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.84508733 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.84508733 |
| 56 | Muscle fiber splitting (HP:0003555) | 2.83181442 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.83132487 |
| 58 | Polycythemia (HP:0001901) | 2.82250471 |
| 59 | Urticaria (HP:0001025) | 2.72898673 |
| 60 | Toxemia of pregnancy (HP:0100603) | 2.72521881 |
| 61 | Cholelithiasis (HP:0001081) | 2.70348989 |
| 62 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.69051951 |
| 63 | Increased IgE level (HP:0003212) | 2.67795085 |
| 64 | Skin nodule (HP:0200036) | 2.66918752 |
| 65 | Metabolic acidosis (HP:0001942) | 2.66392389 |
| 66 | Glomerulonephritis (HP:0000099) | 2.64590121 |
| 67 | Epistaxis (HP:0000421) | 2.63206138 |
| 68 | Delayed CNS myelination (HP:0002188) | 2.62882155 |
| 69 | Myoglobinuria (HP:0002913) | 2.62156855 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.61564906 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.60879473 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.60602829 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.57527578 |
| 74 | Cellulitis (HP:0100658) | 2.56454480 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.55763374 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55106666 |
| 77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.54091191 |
| 78 | Esophageal varix (HP:0002040) | 2.53897173 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52914028 |
| 80 | Oligomenorrhea (HP:0000876) | 2.51050753 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.50535165 |
| 82 | Meningitis (HP:0001287) | 2.50427385 |
| 83 | Granulocytopenia (HP:0001913) | 2.48392138 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47218417 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 2.46403265 |
| 86 | Optic neuritis (HP:0100653) | 2.46403265 |
| 87 | Stomatitis (HP:0010280) | 2.46387252 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44102563 |
| 89 | Obstructive lung disease (HP:0006536) | 2.44102563 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.43563927 |
| 91 | Acanthocytosis (HP:0001927) | 2.42559298 |
| 92 | Poikilocytosis (HP:0004447) | 2.41716735 |
| 93 | Vasculitis (HP:0002633) | 2.41686407 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41673218 |
| 95 | Amyloidosis (HP:0011034) | 2.41355585 |
| 96 | Mitral stenosis (HP:0001718) | 2.39617456 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.34947504 |
| 98 | Vascular calcification (HP:0004934) | 2.32547100 |
| 99 | Gout (HP:0001997) | 2.31825199 |
| 100 | Paralysis (HP:0003470) | 2.30614671 |
| 101 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30099221 |
| 102 | Ileus (HP:0002595) | 2.27883612 |
| 103 | Acanthosis nigricans (HP:0000956) | 2.27657462 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 2.25981642 |
| 105 | Steatorrhea (HP:0002570) | 2.24797472 |
| 106 | Gingival bleeding (HP:0000225) | 2.24637977 |
| 107 | Hypoglycemic seizures (HP:0002173) | 2.24433480 |
| 108 | Mediastinal lymphadenopathy (HP:0100721) | 2.21736881 |
| 109 | Lethargy (HP:0001254) | 2.21235696 |
| 110 | Gingivitis (HP:0000230) | 2.21219711 |
| 111 | Generalized aminoaciduria (HP:0002909) | 2.20920509 |
| 112 | Recurrent fungal infections (HP:0002841) | 2.19631567 |
| 113 | Nephritis (HP:0000123) | 2.18646515 |
| 114 | Spontaneous abortion (HP:0005268) | 2.17437761 |
| 115 | Late onset (HP:0003584) | 2.17265822 |
| 116 | Easy fatigability (HP:0003388) | 2.15874663 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.15849554 |
| 118 | Hypertriglyceridemia (HP:0002155) | 2.15311052 |
| 119 | Petechiae (HP:0000967) | 2.14498897 |
| 120 | Reticulocytosis (HP:0001923) | 2.14169897 |
| 121 | Leukocytosis (HP:0001974) | 2.14080094 |
| 122 | Growth hormone excess (HP:0000845) | 2.12371332 |
| 123 | Gastrointestinal dysmotility (HP:0002579) | 2.09465979 |
| 124 | Thoracic kyphosis (HP:0002942) | 2.09344754 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.09203212 |
| 126 | Chest pain (HP:0100749) | 2.08618620 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 2.08579296 |
| 128 | Cardiovascular calcification (HP:0011915) | 2.08432526 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 2.06544555 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05422458 |
| 131 | Cerebral edema (HP:0002181) | 2.05128131 |
| 132 | Vomiting (HP:0002013) | 2.03344601 |
| 133 | Thrombophlebitis (HP:0004418) | 2.03204939 |
| 134 | Eosinophilia (HP:0001880) | 2.02438494 |
| 135 | Pustule (HP:0200039) | 2.02261836 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 2.01390744 |
| 137 | Osteomyelitis (HP:0002754) | 2.01331260 |
| 138 | Purpura (HP:0000979) | 2.00634089 |
| 139 | Menorrhagia (HP:0000132) | 2.00170657 |
| 140 | Exercise-induced myalgia (HP:0003738) | 2.00051357 |
| 141 | Keratoconjunctivitis (HP:0001096) | 1.99293934 |
| 142 | Rhabdomyolysis (HP:0003201) | 1.97496081 |
| 143 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97322687 |
| 144 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97322687 |
| 145 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97322687 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96275400 |
| 147 | Cholecystitis (HP:0001082) | 1.95723873 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 1.95723873 |
| 149 | EMG: myopathic abnormalities (HP:0003458) | 1.95195794 |
| 150 | Increased connective tissue (HP:0009025) | 1.95171098 |
| 151 | Autoimmune hemolytic anemia (HP:0001890) | 1.92297883 |
| 152 | Axonal loss (HP:0003447) | 1.92225443 |
| 153 | Neonatal onset (HP:0003623) | 1.92090277 |
| 154 | Encephalitis (HP:0002383) | 1.91860802 |
| 155 | Increased serum ferritin (HP:0003281) | 1.91059645 |
| 156 | Neck muscle weakness (HP:0000467) | 1.90986073 |
| 157 | Acute hepatic failure (HP:0006554) | 1.90380714 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.89463601 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.89463601 |
| 160 | Hypercortisolism (HP:0001578) | 1.89404249 |
| 161 | Atrioventricular block (HP:0001678) | 1.89092484 |
| 162 | Aortic aneurysm (HP:0004942) | 1.88811568 |
| 163 | Pancreatitis (HP:0001733) | 1.88190716 |
| 164 | Spastic diplegia (HP:0001264) | 1.87473052 |
| 165 | Dysostosis multiplex (HP:0000943) | 1.87004810 |
| 166 | Nausea (HP:0002018) | 1.86934510 |
| 167 | Asymmetric septal hypertrophy (HP:0001670) | 1.86162842 |
| 168 | Pulmonary embolism (HP:0002204) | 1.85851304 |
| 169 | Spontaneous hematomas (HP:0007420) | 1.85603279 |
| 170 | Pulmonary infiltrates (HP:0002113) | 1.85228519 |
| 171 | Recurrent skin infections (HP:0001581) | 1.85127613 |
| 172 | Increased muscle lipid content (HP:0009058) | 1.84654514 |
| 173 | Stroke (HP:0001297) | 1.84620564 |
| 174 | Agammaglobulinemia (HP:0004432) | 1.83046328 |
| 175 | Autoimmune thrombocytopenia (HP:0001973) | 1.82785395 |
| 176 | Irritability (HP:0000737) | 1.79406807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.38560660 |
| 2 | TRIB3 | 3.63095711 |
| 3 | ERN1 | 3.56156168 |
| 4 | SIK1 | 3.46697593 |
| 5 | FGFR4 | 3.26186822 |
| 6 | TIE1 | 2.77550835 |
| 7 | KDR | 2.64933394 |
| 8 | FES | 2.64376550 |
| 9 | PKN2 | 2.55229053 |
| 10 | TGFBR2 | 2.36937677 |
| 11 | TYK2 | 2.15854108 |
| 12 | PRPF4B | 2.04319071 |
| 13 | TTN | 1.97503916 |
| 14 | MARK3 | 1.89741113 |
| 15 | INSRR | 1.88723189 |
| 16 | RIPK4 | 1.86482465 |
| 17 | TAOK3 | 1.78222338 |
| 18 | TNK2 | 1.77585478 |
| 19 | MAP4K1 | 1.74303579 |
| 20 | MAP3K13 | 1.70042024 |
| 21 | TAOK1 | 1.68708837 |
| 22 | ARAF | 1.66265451 |
| 23 | CAMK1D | 1.61510567 |
| 24 | JAK1 | 1.61475240 |
| 25 | TBK1 | 1.59457095 |
| 26 | EPHB1 | 1.56234802 |
| 27 | PHKG2 | 1.50898106 |
| 28 | PHKG1 | 1.50898106 |
| 29 | TAOK2 | 1.50349269 |
| 30 | MAP2K3 | 1.49883682 |
| 31 | RIPK1 | 1.47422153 |
| 32 | LMTK2 | 1.40863123 |
| 33 | NEK9 | 1.38990744 |
| 34 | MAPK12 | 1.36569207 |
| 35 | MAPK11 | 1.34149362 |
| 36 | JAK2 | 1.33538629 |
| 37 | FLT3 | 1.30702161 |
| 38 | PTK6 | 1.30112543 |
| 39 | PRKAA2 | 1.28035191 |
| 40 | MAP3K7 | 1.25652748 |
| 41 | MAP3K6 | 1.21430497 |
| 42 | PINK1 | 1.19884766 |
| 43 | KIT | 1.19451253 |
| 44 | FGFR3 | 1.16595001 |
| 45 | MYLK | 1.15034979 |
| 46 | IKBKE | 1.11125670 |
| 47 | IRAK3 | 1.09882979 |
| 48 | CSK | 1.04979493 |
| 49 | MARK2 | 1.03740415 |
| 50 | KSR2 | 1.01452292 |
| 51 | OBSCN | 0.98875685 |
| 52 | CAMK1G | 0.98484004 |
| 53 | JAK3 | 0.96780934 |
| 54 | GRK5 | 0.96205674 |
| 55 | IRAK4 | 0.92499736 |
| 56 | MST1R | 0.91960742 |
| 57 | PIM1 | 0.91342221 |
| 58 | PIK3CG | 0.88240475 |
| 59 | MAP3K3 | 0.87019362 |
| 60 | ZAP70 | 0.86327045 |
| 61 | FGFR2 | 0.84816388 |
| 62 | CSF1R | 0.83177855 |
| 63 | TRPM7 | 0.82392999 |
| 64 | PDK4 | 0.80824793 |
| 65 | PDK3 | 0.80824793 |
| 66 | ICK | 0.79918710 |
| 67 | PDPK1 | 0.79868597 |
| 68 | GRK6 | 0.78770899 |
| 69 | TXK | 0.77327303 |
| 70 | PDK2 | 0.76724202 |
| 71 | MAP2K4 | 0.75790401 |
| 72 | MOS | 0.75753419 |
| 73 | ERBB4 | 0.75593177 |
| 74 | SGK3 | 0.75563208 |
| 75 | PRKD2 | 0.75526174 |
| 76 | EPHA3 | 0.75222730 |
| 77 | STK38 | 0.73252264 |
| 78 | PRKAA1 | 0.72599756 |
| 79 | MAP3K10 | 0.72469652 |
| 80 | HIPK2 | 0.72054053 |
| 81 | MAPK4 | 0.70971399 |
| 82 | LCK | 0.70630987 |
| 83 | RAF1 | 0.69915135 |
| 84 | MAP3K14 | 0.69893975 |
| 85 | ITK | 0.68058637 |
| 86 | ABL2 | 0.68033358 |
| 87 | LYN | 0.67855361 |
| 88 | DAPK2 | 0.67683882 |
| 89 | LATS1 | 0.67659510 |
| 90 | PIK3CA | 0.67587619 |
| 91 | FGR | 0.66436326 |
| 92 | MAPK7 | 0.64975986 |
| 93 | BLK | 0.64717226 |
| 94 | SGK223 | 0.64389869 |
| 95 | SGK494 | 0.64389869 |
| 96 | PDK1 | 0.64103495 |
| 97 | SIK3 | 0.63266145 |
| 98 | PRKD1 | 0.62713015 |
| 99 | CDK6 | 0.62676568 |
| 100 | GRK7 | 0.62085420 |
| 101 | LRRK2 | 0.61190634 |
| 102 | PRKCH | 0.60236342 |
| 103 | BMX | 0.60196286 |
| 104 | CAMK1 | 0.58310836 |
| 105 | CDC42BPA | 0.58200022 |
| 106 | CAMK4 | 0.56659781 |
| 107 | BTK | 0.56619808 |
| 108 | PRKACG | 0.55357753 |
| 109 | RPS6KC1 | 0.55158031 |
| 110 | RPS6KL1 | 0.55158031 |
| 111 | MUSK | 0.54518509 |
| 112 | RPS6KA2 | 0.54039528 |
| 113 | DMPK | 0.53888699 |
| 114 | MAP3K11 | 0.53508646 |
| 115 | HCK | 0.51755684 |
| 116 | EEF2K | 0.50688680 |
| 117 | PRKCQ | 0.50622491 |
| 118 | MAP2K2 | 0.49424723 |
| 119 | STK10 | 0.46815468 |
| 120 | STK4 | 0.46057958 |
| 121 | IGF1R | 0.45744616 |
| 122 | DYRK3 | 0.45434406 |
| 123 | GSK3A | 0.45237704 |
| 124 | SIK2 | 0.45020383 |
| 125 | TESK2 | 0.43958583 |
| 126 | RET | 0.43648577 |
| 127 | ERBB2 | 0.43494372 |
| 128 | RPS6KA6 | 0.42412633 |
| 129 | MAPK15 | 0.41563259 |
| 130 | PDGFRA | 0.41516312 |
| 131 | EIF2AK1 | 0.41380737 |
| 132 | TESK1 | 0.40896016 |
| 133 | SGK2 | 0.40891859 |
| 134 | CDK9 | 0.40717227 |
| 135 | TEC | 0.39204592 |
| 136 | MAP3K1 | 0.38270017 |
| 137 | MAPKAPK3 | 0.38200721 |
| 138 | SYK | 0.37684253 |
| 139 | CLK1 | 0.36767269 |
| 140 | EGFR | 0.34936136 |
| 141 | PTK2B | 0.34545826 |
| 142 | DYRK1B | 0.34165698 |
| 143 | GRK1 | 0.33549317 |
| 144 | MAP3K5 | 0.32503998 |
| 145 | PKN1 | 0.32239343 |
| 146 | IKBKB | 0.31498797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.02626949 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73474917 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28723303 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.00424649 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90489634 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86283243 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73289731 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64941083 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58418385 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53267575 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51486050 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46754856 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.29810013 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.25031286 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20179864 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.12711825 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09147754 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.05839800 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05637055 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99604663 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99296577 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96160941 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86771764 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80153852 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72556383 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70339782 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.63705629 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62285587 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61292036 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52818256 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52422576 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51959175 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51145929 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50630624 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47329345 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45539445 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44549210 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.43583288 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42667980 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40134070 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39617085 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37610652 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36475835 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36223210 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.35939979 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32364400 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32248294 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31066907 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30618675 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28769392 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28085331 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27709091 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25743385 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25052823 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24477301 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20292020 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17752095 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17370741 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17005371 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16525754 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14877595 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13494405 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12891078 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11640423 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11129401 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10714323 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 1.08708117 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06906457 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06879423 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06507627 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00995434 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00719595 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00497637 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 1.00265811 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.99877493 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99666138 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98931309 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98055575 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97169224 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97158051 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95183424 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91603350 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89353659 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87945798 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.87524915 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87210258 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86695362 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86367788 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84189326 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.83844817 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83185390 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82328303 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.81716915 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81611422 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80749330 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.80148256 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75420011 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74292828 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72504746 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72335671 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71908713 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69733527 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67634715 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67483098 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67396298 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.66831471 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.66009885 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64993615 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63445881 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62476381 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62430604 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62139905 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62072875 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.59743258 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58189998 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57973418 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.57816498 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57429455 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57309286 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56877544 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55343496 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54834149 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54724656 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53078283 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52464000 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52291804 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51480087 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51275628 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50053756 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46999578 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44275404 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36826653 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35688087 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.35411680 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27774157 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27472663 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27164113 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26458948 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26019356 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25258737 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19810908 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19764271 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17216868 |
| 144 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15135724 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14648039 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.11080561 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09632874 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06367044 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05718371 |
| 150 | Malaria_Homo sapiens_hsa05144 | 0.03878462 |
| 151 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.01057310 |
| 152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1021655 |
| 153 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0999811 |
| 154 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0999466 |
| 155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0882607 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0823589 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0578114 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | -0.0487604 |
| 159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0458603 |
| 160 | Pertussis_Homo sapiens_hsa05133 | -0.0395634 |
| 161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0363749 |
| 162 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0338925 |
| 163 | Hepatitis C_Homo sapiens_hsa05160 | -0.0215279 |
| 164 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0183797 |
| 165 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0032946 |

